# Measuring Oncological Value of Exercise and Statin

> **NCT05796973** · PHASE3 · RECRUITING · sponsor: **Tampere University Hospital** · enrollment: 240 (estimated)

## Conditions studied

- Prostate Cancer
- Breast Cancer
- Kidney Cancer
- Ovarian Cancer
- Metastatic Breast Cancer
- Metastatic Kidney Cancer
- Metastatic Renal Cell Carcinoma
- Metastatic Renal Cancer
- Metastatic Prostate Cancer
- Metastatic Prostate Adenocarcinoma
- Metastatic Ovarian Cancer
- Metastatic Ovary Cancer

## Interventions

- **BEHAVIORAL:** Guided physical exercise
- **DRUG:** Atorvastatin
- **OTHER:** Independent exercise

## Key facts

- **NCT ID:** NCT05796973
- **Lead sponsor:** Tampere University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-03-31
- **Primary completion:** 2027-12-31
- **Final completion:** 2027-12-31
- **Target enrollment:** 240 (ESTIMATED)
- **Last updated:** 2025-06-27

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05796973

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05796973, "Measuring Oncological Value of Exercise and Statin". Retrieved via AI Analytics 2026-08-18 from https://api.ai-analytics.org/clinical/NCT05796973. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*